Simultaneous Analysis of Nitrate and Nitrite Ions in Pharmaceutical Additives

Significance of the Topic

Anion analysis of nitrite and nitrate is critical in pharmaceutical excipients to prevent nitrosamine formation, thereby reducing carcinogenic risk. Regulatory authorities such as the US FDA and the European Pharmacopoeia mandate monitoring these impurities to ensure drug safety.

Study Objectives and Overview

This application note demonstrates a method for simultaneous trace‐level quantitation of nitrite and nitrate ions in common pharmaceutical additives. The primary goals were to simplify sample pretreatment and achieve high sensitivity (µg/L) detection using suppressor‐based ion chromatography with UV detection.

Used Instrumentation

• Suppressor‐type ion chromatograph HIC‐ESP
• UV detector (210 nm)
• Shim-pack IC-SA3 analytical column (250 mm × 4.0 mm I.D., 5 µm)
• Shim-pack IC-SA3(G) guard column (10 mm × 4.6 mm I.D., 5 µm)

Methodology

The separation employed a 3.6 mmol/L sodium carbonate eluent at 0.8 mL/min, with column temperature at 45 °C and a 50 µL injection volume. Calibration standards ranged from 0.002 to 0.1 mg/L for both ions, yielding linear calibration curves. Sample preparation involved dissolving or extracting 0.1–0.5 g of excipient in ultrapure water, shaking, centrifugation, and 0.2 µm filtration prior to analysis.

Results and Discussion

Calibration curves exhibited excellent linearity (R² > 0.9998). Chromatograms at the lowest standard level (0.002 mg/L) clearly resolved nitrite and nitrate peaks. Analytical precision was confirmed by recoveries of 95–100% across three excipients: polyvinyl alcohol, silicic acid anhydride, and sodium stearyl fumarate. Trace levels of both ions were detected in all samples.

Benefits and Practical Applications

• Minimal, water‐based sample pretreatment
• High sensitivity suitable for regulatory compliance
• Versatile for multiple pharmaceutical excipients
• Suppressor‐based design enables expanded anion profiling

Future Trends and Potential Applications

Future developments may include automated sample handling for higher throughput, extension to other anionic contaminants (e.g., halides, organic acids), and coupling with mass spectrometry for enhanced specificity. Innovations in greener eluents and column materials could reduce analysis time and environmental impact.

Conclusion

The suppressor‐based ion chromatography method coupled with UV detection provides a reliable, high‐sensitivity approach for determining nitrite and nitrate in pharmaceutical additives. Its straightforward pretreatment, robust linearity, and strong recoveries support stringent quality control and regulatory requirements.

References

• FDA Control of Nitrosamine Impurities in Human Drugs. U.S. Food and Drug Administration Guidance, 2021.
• European Pharmacopoeia General Monographs on Nitrosamines. European Directorate for the Quality of Medicines, 2018.